Gastrointestinal stem cells in development and cancer

Journal of Pathology

Volumn 217, Issue 2, 2009, Pages 307-317

  Brabletz, S ^a   Schmalhofer, O ^a   Brabletz, T ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

catenin; Cancer stem cells; EMT; GI tract; Intestinal stem cells; Metastasis; Stem cell niche

Indexed keywords

BETA CATENIN; BONE MORPHOGENETIC PROTEIN; NOTCH RECEPTOR; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; SONIC HEDGEHOG PROTEIN; WNT PROTEIN;

BENIGN TUMOR; CANCER GROWTH; CANCER INVASION; CANCER STEM CELL; CARCINOGENESIS; CELL DIFFERENTIATION; CELL MATURATION; CELL MIGRATION; CELLULAR DISTRIBUTION; COLORECTAL CANCER; DIGESTIVE SYSTEM CANCER; EPITHELIAL MESENCHYMAL TRANSITION; GASTRULATION; GENE; GENE MUTATION; HUMAN; INTESTINAL STEM CELL; INTESTINE CELL; LGR5 GENE; MALIGNANT TRANSFORMATION; MESENCHYMAL STEM CELL; METASTASIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; STEM CELL; TUMOR GROWTH;

ANIMALS; CELL DIFFERENTIATION; CELL TRANSFORMATION, NEOPLASTIC; GASTROINTESTINAL NEOPLASMS; GASTROINTESTINAL TRACT; HUMANS; NEOPLASTIC STEM CELLS; SIGNAL TRANSDUCTION; STEM CELL NICHE; STEM CELLS;

EID: 58449088387     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.2475     Document Type: Review

References (123)

1. de Santa Barbara P, van den Brink GR, Roberts DJ. Development and differentiation of the intestinal epithelium. Cell Mol Life Sci 2003;60:1322-1332.
2. Calvert R, Pother P. Migration of fetal intestinal intervillous cells in neonatal mice. Anat Rec 1990;227:199-206.
3. Schmidt GH, Winton DJ, Ponder BA. Development of the pattern of cell renewal in the crypt-villus unit of chimaeric mouse small intestine. Development 1988;103:785-790.
4. Scoville DH, Sato T, He XC, Li L. Current view: intestinal stem cells and signaling. Gastroenterology 2008;134:849-864.
5. Brittan M, Wright NA. Gastrointestinal stem cells. J Pathol 2002;197:492-509.
6. Bjerknes M, Cheng H. Clonal analysis of mouse intestinal epithelial progenitors. Gastroenterology 1999;116:7-14.
7. Hermiston ML, Green RP, Gordon JI. Chimeric-transgenic mice represent a powerful tool for studying how the proliferation and differentiation programs of intestinal epithelial cell lineages are regulated. Proc Natl Acad Sci USA 1993;90:8866-8870.
8. Novelli M, Cossu A, Oukrif D, Quaglia A, Lakhani S, Poul- som R, et al. X-inactivation patch size in human female tissue confounds the assessment of tumor clonality. Proc Natl Acad Sci USA 2003;100:3311-3314.
9. Roth KA, Hermiston ML, Gordon JI. Use of transgenic mice to infer the biological properties of small intestinal stem cells and to examine the lineage relationships of their descendants. Proc NatlAcadSci USA 1991;88:9407-9411.
10. Marshman E, Booth C, Potten CS. The intestinal epithelial stem cell. Bioessays 2002;24:91-98.
11. Potten CS, Booth C, Tudor GL, Booth D, Brady G, Hurley P, et al. Identification of a putative intestinal stem cell and early lineage marker; musashi-1. Differentiation 2003;71:28-41.
12. Potten CS, Owen G, Booth D. Intestinal stem cells protect their genome by selective segregation oftemplate DNA strands. JCell Sci 2002;115:2381-2388.
13. Barker N, van Es JH, Kuipers J, Kujala P, van den Born M, Cozijnsen M, et al. Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature 2007;449:1003-1007.
14. Cheng H, Leblond CP. Origin, differentiation and renewal of the four main epithelial cell types in the mouse small intestine. I. Columnar cell. Am J Anat 1974;141:461-479.
15. Bjerknes M, Cheng H. The stem-cell zone of the small intestinal epithelium. IV. Effects of resecting 30% of the small intestine. Am J Anat 1981;160:93-103.
16. Kayahara T, Sawada M, Takaishi S, Fukui H, Seno H, Fukuzawa H, et al. Candidate markers for stem and early progenitor cells, Musashi-1 and Hes1, are expressed in crypt base columnar cells of mouse small intestine. FEBS Lett 2003;535:131-135.
17. Sureban SM, May R, George RJ, Dieckgraefe BK, McLeod HL, Ramalingam S, et al. Knockdown of RNA binding protein Musashi-1 leads to tumor regression in vivo. Gastroenterology 2008;134:1448-1458.e1442.
18. Okano H, Imai T, Okabe M. Musashi: a translational regulator of cell fate. J Cell Sci 2002;115:1355-1359.
19. Sangiorgi E, Capecchi MR. Bmi1 is expressed in vivo in intestinal stem cells. Nat Genet 2008;40:915-920.
20. Barker N, Clevers H. Tracking down the stem cells of the intestine: strategies to identify adult stem cells. Gastroenterology 2007;133:1755-1760.
21. Behrens J, von Kries JP, Kuhl M, Bruhn L, Wedlich D, Grosschedl R, et al. Functional interaction of ß -catenin with the transcription factor LEF-1. Nature 1996;382:638-642.
22. Groden J, Thliveris A, Samowitz W, Carlson M, Gelbert L, Albertsen H, et al. Identification and characterization of the familial adenomatous polyposis coli gene. Cell 1991;66:589-600.
23. Kinzler KW, Nilbert MC, Su LK, Vogelstein B, Bryan TM, Levy DB, et al. Identification of FAP locus genes from chromosome 5q21. Science 1991;253:661-665.
24. -/- colon carcinoma [see comments]. Science 1997;275:1784-1787.
25. Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogel- stein B, et al. Activation of ß-catenin-Tcf signaling in colon cancer by mutations in ß-catenin or APC [see comments]. Science 1997;275:1787-1790.
26. Munemitsu S, Albert I, Souza B, Rubinfeld B, Polakis P. Regulation of intracellular ß-catenin levels by the adenomatous polyposis coli (APC) tumor-suppressor protein. Proc Natl Acad Sci USA 1995;92:3046- 3050.
27. Rubinfeld B, Albert I, Porfiri E, Fiol C, Munemitsu S, Polakis P. Binding of GSK3ß to the APC-ß-catenin complex and regulation of complex assembly. Science 1996;272:1023-1026.
28. Rubinfeld B, Souza B, Albert I, Muller O, Chamberlain SH, Masiarz FR, et al. Association of the APC gene product withß-catenin. Science 1993;262:1731-1734.
29. Fodde R, Brabletz T. Wnt/ß-catenin signaling in cancer stemness and malignant behavior. Curr Opin Cell Biol 2007;19:1-9.
30. Gregorieff A, Clevers H. Wnt signaling in the intestinal epithelium: from endoderm to cancer. Genes Dev 2005;19:877-890.
31. Huelsken J, Behrens J. The Wnt signalling pathway. J Cell Sci 2000;113(20):3545.
32. Clevers H. Wnt/ß-catenin signaling in development and disease. Cell 2006;127:469-480.
33. Fodde R, Edelmann W, Yang K, van Leeuwen C, Carlson C, Renault B, et al. A targeted chain-termination mutation in the mouse Apc gene results in multiple intestinal tumors. Proc Natl Acad Sci USA 1994;91:8969-8973.
34. Harada N, Tamai Y, Ishikawa T, Sauer B, Takaku K, Oshima M, et al. Intestinal polyposis in mice with a dominant stable mutation of the ß-catenin gene. EMBO J 1999;18:5931-5942.
35. Kucherlapati R, Lin DP, Edelmann W. Mouse models for human familial adenomatous polyposis. Semin Cancer Biol 2001;11:219-225.
36. Oshima M, Oshima H, Kitagawa K, Kobayashi M, Itakura C, Taketo M. Loss of Apc heterozygosity and abnormal tissue building in nascent intestinal polyps in mice carrying a truncated Apc gene. Proc Natl Acad Sci USA 1995;92:4482-4486.
37. Smits R, Kielman MF, Breukel C, Zurcher C, Neufeld K, Jagmohan-Changur S, et al. Apc1638T: a mouse model delineating critical domains of the adenomatous polyposis coli protein involved in tumorigenesis and development. Genes Dev 1999;13:1309-1321.
38. Huelsken J, Vogel R, Erdmann B, Cotsarelis G, Birchmeier W. ß-Catenin controls hair follicle morphogenesis and stem cell differentiation in the skin. Cell 2001;105:533-545.
39. Nguyen H, Rendl M, Fuchs E. Tcf3 governs stem cell features and represses cell fate determination in skin. Cell 2006;127:171-183.
40. Reya T, Duncan AW, Ailles L, Domen J, Scherer DC, Willert K, et al. A role for Wnt signalling in self-renewal of haematopoietic stem cells. Nature 2003;423:409-414.
41. Zechner D, Fujita Y, Hulsken J, Muller T, Walther I, Taketo MM, et al. ß-Catenin signals regulate cell growth and the balance between progenitor cell expansion and differentiation in the nervous system. Dev Biol 2003;258:406-418.
42. Lickert H, Kutsch S, Kanzler B, Tamai Y, Taketo MM, Kem-ler R. Formation of multiple hearts in mice following deletion of ß-catenin in the embryonic endoderm. Dev Cell 2002;3:171-181.
43. Korinek V, Barker N, Moerer P, van Donselaar E, Huls G, Peters PJ, et al. Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4. Nat Genet 1998;19:379-383.
44. He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, et al. Identification of c-MYC as a target of the APC pathway [see comments]. Science 1998;281:1509-1512.
45. Shtutman M, Zhurinsky J, Simcha I, Albanese C, D'Amico M, Pestell R, et al.Thecyclin D1 gene is a target of the ß-catenin/LEF-1 pathway. Proc Natl Acad Sci USA 1999;96:5522-5527.
46. Tetsu O, McCormick F. ß-Catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 1999;398:422-426.
47. Batlle E, Henderson JT, Beghtel H, van den Born MM, Sancho E, Huls G, et al. ß-Catenin and TCF mediate cell positioning in the intestinal epithelium by controlling the expression of EphB/ephrinB. Cell 2002;111:251-263.
48. Brabletz T, Jung A, Dag S, Hlubek F, Kirchner T. ß-Catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer. Am JPathol 1999;155:1033-1038.
49. Crawford HC, Fingleton BM, Rudolph-Owen LA, Heppner Goss KJ, Rubinfeld B, Polakis P, et al. The metalloproteinase Matrilysin is a target of ß-catenin transactivation in intestinaltumors. Oncogene 1999;18:2883-2891.
50. van Es JH, Jay P, Gregorieff A, van Gijn ME, Jonkheer S, Hatzis P, et al. Wnt signalling induces maturation of Paneth cells in intestinal crypts. Nat Cell Biol 2005;7:381-386.
51. Hlubek F, Jung A, Kotzor N, Kirchner T, Brabletz T. Expression of the invasion factor laminin γ 2 in colorectal carcinomas is regulated by ß-catenin. Cancer Res 2001;61:8089-8093.
52. Conacci-Sorrell M, Simcha I, Ben-Yedidia T, Blechman J, Savagner P, Ben-Ze'ev A. Autoregulation of E-cadherin expression by cadherin-cadherin interactions: the roles of ß-catenin signaling, Slug, and MAPK. J Cell Biol 2003;163:847-857.
53. Cully M, You H, Levine AJ, Mak TW. Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis. Nat Rev Cancer 2006;6:184-192.
54. Parsons DW, Wang TL, Samuels Y, Bardelli A, Cummins JM, DeLong L, et al. Colorectal cancer: mutations in a signalling pathway. Nature 2005;436:792.
55. He XC, Zhang J, Tong WG, Tawfik O, Ross J, Scoville DH, et al. BMP signaling inhibits intestinal stem cell self-renewal through suppression of Wnt-ß-catenin signaling. Nat Genet 2004;36:1117-1121.
56. He XC, Yin T, Grindley JC, Tian Q, Sato T, Tao WA, et al. PTEN-deficient intestinal stem cells initiate intestinal polyposis. Nat Genet 2007;39:189-198.
57. Persad S, Troussard AA, McPhee TR, Mulholland DJ, Dedhar S. Tumor suppressor PTEN inhibits nuclear accumulation of ß-catenin and T ceMymphoid enhancer factor 1-mediated transcriptional activation. J Cell Biol 2001;153:1161-1174.
58. Kim S, Domon-Dell C, Wang Q, Chung DH, Di Cristofano A, Pandolfi PP, et al. PTEN and TNFα regulation of the intestinal-specific Cdx-2 homeobox gene through a PI3K, PKB/Akt, and NF-kB-dependent pathway. Gastroenterology 2002;123:1163-1178.
59. von Bubnoff A, Cho KW. Intracellular BMP signaling regulation in vertebrates: pathway or network? Dev Biol 2001;239:1-14.
60. Haramis AP, Begthel H, van den Born M, van Es J, Jonkheer S, Offerhaus GJ, et al. De novo crypt formation and juvenile polyposis on BMP inhibition in mouse intestine. Science 2004;303:1684-1686.
61. Auclair BA, Benoit YD, Rivard N, Mishina Y, Perreault N. Bone morphogenetic protein signaling is essential for terminal differentiation of the intestinal secretory cell lineage. Gastroen- terology 2007;133:887-896.
62. Howe JR, Bair JL, Sayed MG, Anderson ME, Mitros FA, Petersen GM, et al. Germline mutations of the gene encoding bone morphogenetic protein receptor 1A in juvenile polyposis. Nat Genet 2001;28:184-187.
63. Howe JR, Roth S, Ringold JC, Summers RW, Jarvinen HJ, Sistonen P, et al. Mutations in the SMAD4/DPC4 gene in juvenile polyposis. Science 1998;280:1086-1088.
64. Hsu DR, Economides AN, Wang X, Eimon PM, Harland RM. The Xenopus dorsalizing factor Gremlin identifies a novel family of secreted proteins that antagonize BMP activities. Mol Cell 1998;1:673-683.
65. Zimmerman LB, De Jesus-Escobar JM, Harland RM. The Spemann organizer signal noggin binds and inactivates bone morphogenetic protein 4. Cell 1996;86:599-606.
66. Kosinksi C, Vivian SWL, Annie SYC, Ji Z, Coral H, Wai YT, et al. Gene expression patterns of human colon tops and basal crypts and BMP antagonists as intestinal stem cell niche factors. Proc Natl Acad Sci 2007;104:15418-15423.
67. Waite KA, Eng C. BMP2 exposure results in decreased PTEN protein degradation and increased PTEN levels. Hum Mol Genet 2003;12:679- 684.
68. Waite KA, Eng C. From developmental disorder to heritable cancer: it's all in the BMP/TGFß family. Nat Rev Genet 2003;4:763-773.
69. Bray SJ. Notch signalling: a simple pathway becomes complex. Nat Rev Mol Cell Biol 2006;7:678-689.
70. Jensen J, Pedersen EE, Galante P, Hald J, Heller RS, Ishibashi M, et al. Control of endodermal endocrine development by Hes-1. Nat Genet 2000;24:36-44.
71. van Es JH, Clevers H. Notch and Wnt inhibitors as potential new drugs for intestinal neoplastic disease. Trends Mol Med 2005;11:496-502.
72. van Es JH, van Gijn ME, Riccio O, van den Born M, Vooijs M, Begthel H, et al.Notch/γ-secretase inhibition turns proliferative cells in intestinal crypts and adenomas into goblet cells. Nature 2005;435:959-963.
73. Yang Q, Bermingham NA, Finegold MJ, Zoghbi HY. Requirement of Math1 for secretory cell lineage commitment in the mouse intestine. Science 2001;294:2155-2158.
74. Riccio O, van Gijn ME, Bezdek AC, Pellegrinet L, van Es JH, Zimber-Strobl U, et al. Loss of intestinal crypt progenitor cells owing to inactivation of both Notch1 and Notch2 is accompanied by derepression of CDK inhibitors p27Kip1 and p57Kip2. EMBO Rep 2008;9:377-383.
75. Naya FJ, Huang HP, Qiu Y, Mutoh H, DeMayo FJ, Leiter AB, et al. Diabetes, defective pancreatic morphogenesis, and abnormal enteroendocrine differentiation in β 2/neuroD-deficient mice. Genes Dev 1997;11:2323-2334.
76. Madison BB, Braunstein K, Kuizon E, Portman K, Qiao XT, Gumucio DL. Epithelial hedgehog signals pattern the intestinal crypt-villus axis. Development 2005;132:279-289.
77. van den Brink GR. Hedgehog signaling in development and homeostasis of the gastrointestinal tract. Physiol Rev 2007;87:1343-1375.
78. van den Brink GR, Bleuming SA, Hardwick JC, Schepman BL, Offerhaus GJ, Keller JJ, et al. Indian Hedgehog is an antagonist of Wnt signaling in colonic epithelial cell differentiation. Nat Genet 2004;36:277- 282.
79. Molenaar M, van de Wetering M, Oosterwegel M, Peterson- Maduro J, Godsave S, Korinek V, et al. XTcf-3 transcription factor mediates ß-catenin-induced axis formation in Xenopus embryos. Cell 1996;86:391-399.
80. Polakis P. Wnt signaling and cancer. Genes Dev 2000; 1837-1851.
81. Potten CS, Kellett M, Rew DA, Roberts SA. Proliferation in human gastrointestinal epithelium using bromodeoxyuridine in vivo: data for different sites, proximity to a tumour, and polyposis coli [see comments]. Gut 1992;33:524-529.
82. Boman BM, Fields JZ, Bonham-Carter O, Runquist OA. Computer modeling implicates stem cell overproduction in colon cancer initiation. Cancer Res 2001;61:8408-8411.
83. Boman BM, Walters R, Fields JZ, Kovatich AJ, Zhang T, Isenberg GA, et al. Colonic crypt changes during adenoma development in familial adenomatous polyposis: immunohistochemical evidence for expansion of the crypt base cell population. Am J Pathol 2004;165:1489-1498.
84. Zhang T, Otevrel T, Gao Z, Ehrlich SM, Fields JZ, Boman BM. Evidence that APC regulates survivin expression: a possible mechanism contributing to the stem cell origin of colon cancer. Cancer Res 2001;61:8664-8667.
85. Greaves LC, Preston SL, Tadrous PJ, Taylor RW, Barron MJ, Oukrif D, et al. Mitochondrial DNA mutations are established in human colonic stem cells, and mutated clones expand by crypt fission. Proc Natl Acad Sci USA 2006;103:714-719.
86. Preston SL, Wong W-M, Chan AO-O, Poulsom R, Jeffery R, Goodlad RA, et al. Bottom-up histogenesis of colorectal adenomas: origin in the monocryptal adenoma and initial expansion by crypt fission. Cancer Res 2003;63:3819-3825.
87. Bjerknes M, Cheng H, Hay K, Gallinger S. APC mutation and the crypt cycle in murine and human intestine. Am J Pathol 1997;150:833-839.
88. Wasan HS, Park HS, Liu KC, Mandir NK, Winnett A, Sasieni P, et al. APC in the regulation of intestinal crypt fission. J Pathol 1998;185:246- 255.
89. Boman BM, Huang E. Human colon cancer stem cells: a new paradigm in gastrointestinal oncology. J Clin Oncol 2008;26:2828-2838.
90. Kim PJ, Plescia J, Clevers H, Fearon ER, Altieri DC. Survivin and molecular pathogenesis of colorectal cancer. Lancet 2003;362:205- 209.
91. Lane N, Lev R. Observations on the origin of adenomatous epithelium of the colon. Serial section of minute polyps in familial polyposis. Cancer 1963;16:751 -764.
92. Lightdale C, Lipkin M, Deschner E. In vivo measurements in familial polyposis: kinetics and location of proliferating cells in colonic adenomas. Cancer Res 1982;42:4280-4283.
93. Brabletz T, Herrmann K, Jung A, Faller G, Kirchner T. Expression of nuclear ß-catenin and c-myc is correlated with tumor size but not with proliferative activity of colorectal adenomas. Am J Pathol 2000;156:865-870.
94. Brabletz T, Jung A, Hermann K, Gunther K, Hohenberger W, Kirchner T. Nuclear overexpression of the oncoprotein ß -catenin in colorectal cancer is localized predominantly at the invasion front. Pathol Res Pract 1998;194:701-704.
95. Kirchner T, Brabletz T. Patterning and nuclear ß-catenin expression in the colonic adenoma-carcinoma sequence: analogies with embryonic gastrulation. Am J Pathol 2000;157:1113-1121.
96. Brabletz T, Hlubek F, Spaderna S, Schmalhofer O, Hiendlmeyer E, Jung A, et al. Invasion and metastasis in colorectal cancer: epithelial- mesenchymal transition, mesenchymal-epithelial transition, stem cells and ß-catenin. Cells Tissues Organs 2005;179:56-65.
97. Brabletz T, Jung A, Kirchner T. ß-catenin and the morphogenesis of colorectal cancer. Virchows Arch 2002;441:1 -11.
98. Brabletz T, Jung A, Reu S, Porzner M, Hlubek F, Kunz- Schughart L, et al.Variable ß-catenin expression in col-orectal cancer indicates a tumor progression driven by the tumor environment. Proc Natl Acad Sci USA 2001;98:10356-10361.
99. Angerer L, Angerer R. Regulative development of the sea urchin embryo: signalling cascades and morphogen gradients. Semin Cell Dev Biol 1999;10:327-334.
100. Chisholm AD. Gastrulation: Wnts signal constriction. Curr Biol 2006;16:R874-876.
101. Gaspar C, Fodde R. APC dosage effects in tumorigenesis and stem cell differentiation. Int J Dev Biol 2004;48:377-386.
102. Janssen KP, Alberici P, Fsihi H, Gaspar C, Breukel C, Franken P, et al. APC and oncogenic KRAS are synergistic in enhancing Wnt signaling in intestinal tumor formation and progression. Gastroenterology 2006;131:1096-1109.
103. Brabletz T, Jung A, Spaderna S, Hlubek F, Kirchner T. Opinion: migrating cancer stem cells - an integrated concept of malignant tumour progression. Nat Rev Cancer 2005;5:744-749.
104. Jung A, Schrauder M, Oswald U, Knoll C, Sellberg P, Palmqvist R, et al. The invasion front of human colorectal adenocarcinomas shows co-localization of nuclear ß-catenin, cyclin D(1), and p16(INK4A) and is a region of low proliferation. Am J Pathol 2001;159:1613-1617.
105. Mani SA, Yang J, Brooks M, Schwaninger G, Zhou A, Miura N, et al. Mesenchyme Forkhead 1 (FOXC2) plays a key role in metastasis and is associated with aggressive basal-like breast cancers. Proc Natl Acad Sci USA 2007;104:10069-10074.
106. Dalerba P, Cho RW, Clarke MF. Cancer stem cells: models and concepts. Annu Rev Med 2007;58:267-284.
107. Polyak K, Hahn WC. Roots and stems: stem cells in cancer. Nat Med 2006;12:296-300.
108. Wicha MS. Cancer stem cells and metastasis: lethal seeds. Clin Cancer Res 2006;12:5606-5607.
109. Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 1997;3:730-737.
110. Zhang M, Rosen JM. Stem cells in the etiology and treatment of cancer. Curr Opin Genet Dev 2006;16:60-64.
111. Clarke MF, Dick JE, Dirks PB, Eaves CJ, Jamieson CH, Jones DL, et al. Cancer stem cells - perspectives on current status and future directions: AACR workshop on cancer stem cells. Cancer Res 2006;66:9339-9344.
112. O'Brien CA, Pollett A, Gallinger S, Dick JE. A human colon cancer cell capable of initiating tumour growth in immunode-ficient mice. Nature 2007;445:106-110.
113. Ricci-Vitiani L, Lombardi DG, Pilozzi E, Biffoni M, Todaro M, Peschle C, et al. Identification and expansion of human colon cancer-initiating cells. Nature 2007;445:111-115.
114. Weigmann A, Corbeil D, Hellwig A, Huttner WB. Prominin, a novel microvilli-specific polytopic membrane protein of the apical surface of epithelial cells, is targeted to plasmalemmal protrusions of non-epithelial cells. Proc Natl Acad Sci USA 1997;94:12425-12430.
115. Mizrak MBMRA. CD133: molecule of the moment. J Pathol 2008;214:3-9.
116. Shmelkov SV, Butler JM, Hooper AT, Hormigo A, Kushner J, Milde T, et al. CD133 expression is not restricted to stem cells, and both CD133 and CD133 metastatic colon cancer cells initiate tumors. J Clin Invest 2008;118:2111-2120.
117. Dalerba P, Dylla SJ, Park IK, Liu R, Wang X, Cho RW, et al. Phenotypic characterization of human colorectal cancer stem cells. Proc Natl Acad Sci USA 2007;104:10158-10163.
118. + hepatocellular carcinoma cells as cancer stem/progenitor cells. Biochem Biophys Res Commun 2006;351:820- 824.
119. Yin S, Li J, Hu C, Chen X, Yao M, Yan M, et al. CD133-positive hepatocellular carcinoma cells possess high capacity for tumorigenicity. Int JCancer 2007;120:1444-1450.
120. Hermann PC, Huber SL, Herrler T, Aicher A, Ellwart JW, Guba M, et al. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 2007;1:313-323.
121. Lee CJ, Dosch J, Simeone DM. Pancreatic cancer stem cells. J Clin Oncol 2008;26:2806-2812.
122. Li C, Heidt DG, Dalerba P, Burant CF, Zhang L, Adsay V, et al. Identification of pancreatic cancer stem cells. Cancer Res 2007;67:1030-1037.
123. Houghton J, Stoicov C, Nomura S, Rogers AB, Carlson J, Li H, et al. Gastric cancer originating from bone marrow-derived cells. Science 2004;306:1568-1571.